Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Evome Medical Technologies Inc V.EVMT

Alternate Symbol(s):  LNDZF

Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. It offers concussion, fall screening and balance assessment and training programs.


TSXV:EVMT - Post by User

Comment by mjh9413on Jun 30, 2021 7:14pm
410 Views
Post# 33477772

RE:RE:RE:Real Possibilities And Great Potential.

RE:RE:RE:Real Possibilities And Great Potential.They had $US6MM  cash in Jan 2020 and difficult to say how  much used up since but there are several insider 10c/20c pre-consolidation options and those 47c compensation options all in-the-money  I wondered about new equity raise here but don't know if it will tempting at these levels when they tell us it is  growth thru acqun company but not much cash needed when, as you say, preribed share emphasis on new acquns.
Interesting, the PHM and Protech connection (no wonder the name change there!) and the Dalsin/Greene connection from the PHM acqun spree from years ago, but the acqun details for SDB make it all very interesting in terms of SGMD management being in the driver's seat even if SDB execs fremain at SDB's helm. Of course, CEO, Cross, had small interest in SDB before joining SGMD...but, of course, that was merely incidental in terms of these common parties!!!.
Sp consolidation at  $1.15 might be temporary but hope next news drives it further before we ever hear word of an equity raise.  JMHO and might take some money off table in case it does happen here. Will have to watch action.
<< Previous
Bullboard Posts
Next >>